Specifically, HAS1 expression in breast carcinoma cells associated with a high relapse rate and short overall survival, while expression levels of stromal HAS1 and HAS2 were positively related to tumor size and lymph node metastasis (41). The gene discussed is HAS1; the disease is metastatic malignant neoplasm in the lymph nodes.